The move follows the World Health Organisation's (WHO) Emergency Use Listing for Covaxin, which is the second most used formulation in India. Covishield, the India-manufactured Oxford-AstraZeneca COVID-19 vaccine, was added to the UK's approved list last month.
from Zee News :India National https://ift.tt/31NOjpX
No comments:
Post a Comment